N-(2-Aminoethyl)-3-(benzo[d][1,3]dioxol-5-yl)-1,2,4-oxadiazole-5-carboxamide

Catalog No. :
ACSOLQ962
CAS No. :
938007-34-2
Molecular Formula :
C12H12N4O4
Molecular Weight :
276.25

IUPAC Name:N-(2-aminoethyl)-3-(benzo[d][1,3]dioxol-5-yl)-1,2,4-oxadiazole-5-carboxamide

N-(2-Aminoethyl)-3-(benzo[d][1,3]dioxol-5-yl)-1,2,4-oxadiazole-5-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$268.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Aminoethyl)-3-(benzo[d][1,3]dioxol-5-yl)-1,2,4-oxadiazole-5-carboxamide
IUPAC NameN-(2-aminoethyl)-3-(benzo[d][1,3]dioxol-5-yl)-1,2,4-oxadiazole-5-carboxamide
MDL No.MFCD08559273
Molecular FormulaC12H12N4O4
Molecular Weight276.25
SMILESO=C(C1=NC(C2=CC=C(OCO3)C3=C2)=NO1)NCCN
InChI KeySREUDGMLKKFVCV-UHFFFAOYSA-N
SynonymN-(2-aminoethyl)-3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazole-5-carboxamide;1,2,4-Oxadiazole-5-carboxamide, N-(2-aminoethyl)-3-(1,3-benzodioxol-5-yl)-;N-(2-Aminoethyl)-3-(1,3-dioxaindan-5-yl)-1,2,4-oxadiazole-5-carboxamide
CAS No.938007-34-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSOLQ962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSOLQ962 route product structure diagram
    ACSOLQ962938007-34-2
Inquiry

2. ACSOLQ962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDOKV094 route compound structure diagram
    ACDOKV09416483-18-4 In Stock
  4. Then
  5. ACSOLQ962 route product structure diagram
    ACSOLQ962938007-34-2
Inquiry

Comments (0)